Manufacture and Supply of Cyclosporine Ophthalmic Ointment (Veterinary Use)

The contract is for the manufacture and supply of a sterile, preservative-free Cyclosporine Ophthalmic Ointment at a concentration of 0.2% per gram, specifically formulated for veterinary use in dogs. The product must be packaged in 3.5 gram tubes, with each set containing six tubes, and must meet all applicable FDA regulatory standards under current Good Manufacturing Practices. A validated 24-month shelf life is required, ensuring stability and efficacy over the product's intended storage period. The ointment is intended for use in military veterinary programs, requiring strict adherence to quality, safety, and consistency protocols throughout production and packaging. The solicitation, issued by the Department of Defense under the Medical Supply Chain Pharm FSA, is classified as a subcontract with a NAICS code of 325412, indicating pharmaceutical preparation manufacturing. The place of performance is designated as APO with ZIP code 09227-0000, suggesting delivery to U.S. military installations overseas. Responses are due by August 10, 2026, following a posting date of August 3, 2026. All submitted proposals must demonstrate full compliance with regulatory and packaging specifications, and suppliers must provide documentation confirming product sterility, preservative-free formulation, and shelf-life validation data.